Cargando…

Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a disastrous condition, which can be caused by a wide range of diseases, such as pneumonia, sepsis, traumas, and the most recent, COVID-19. Even though we have gained an improved understanding of acute lung injury/acute respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wenfang, Zhang, Yiwen, Wang, Yinghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815466/ https://www.ncbi.nlm.nih.gov/pubmed/36618910 http://dx.doi.org/10.3389/fphar.2022.1103309

Ejemplares similares

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
por: Xu, Yishi, et al.
Publicado: (2023)

Immunotherapy Summary for Cytokine Storm in COVID-19
por: Li, Yaqun, et al.
Publicado: (2021)

Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury
por: Jin, Hua, et al.
Publicado: (2021)

Elucidation of the Mechanism of Action of Ginseng Against Acute Lung Injury/Acute Respiratory Distress Syndrome by a Network Pharmacology-Based Strategy
por: Ding, Qi, et al.
Publicado: (2021)

Highway to heal: Influence of altered extracellular matrix on infiltrating immune cells during acute and chronic lung diseases
por: Joglekar, Mugdha M., et al.
Publicado: (2022)

Human amnion-derived mesenchymal stem cells attenuate acute lung injury in two different acute lung injury mice models
por: Wu, Yuxuan, et al.
Publicado: (2023)

Ferroptosis, a New Insight Into Acute Lung Injury
por: Yin, Xiaofang, et al.
Publicado: (2021)

Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles—A Novel Strategy for Enhancement of the Anti-tumor Immune Response
por: Markov, Oleg, et al.
Publicado: (2019)

The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy
por: He, Jia-shuai, et al.
Publicado: (2021)

Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022)

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
por: Rolandsson Enes, Sara, et al.
Publicado: (2021)

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis
por: Lin, Li, et al.
Publicado: (2023)

Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis
por: Zhang, Yue, et al.
Publicado: (2023)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles
por: Wen, Shaohua, et al.
Publicado: (2022)

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
por: Zheng, Yang, et al.
Publicado: (2023)

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab
por: Niewada, Maciej, et al.
Publicado: (2023)

Next-Generation Immunotherapies to Improve Anticancer Immunity
por: Shi, Yaoyao, et al.
Publicado: (2021)

Inflammatory Caspases Drive Pyroptosis in Acute Lung Injury
por: Liu, Bohao, et al.
Publicado: (2021)

Qi-Dong-Huo-Xue-Yin balances the immune microenvironment to protect against LPS induced acute lung injury
por: zhao, Tian, et al.
Publicado: (2023)

Proteomic analysis revealed the pharmacological mechanism of Xueshuantong injection in preventing early acute myocardial infarction injury
por: Wang, Aoao, et al.
Publicado: (2022)

Ligustrazine Alleviate Acute Lung Injury Through Suppressing Pyroptosis and Apoptosis of Alveolar Macrophages
por: Jiang, Rundong, et al.
Publicado: (2021)

CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis
por: Pouzol, Laetitia, et al.
Publicado: (2021)

Administration of protopine prevents mitophagy and acute lung injury in sepsis
por: Xiao, Zhong, et al.
Publicado: (2023)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
por: Fu, Yang, et al.
Publicado: (2022)

Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
por: Li, Lingling, et al.
Publicado: (2022)

Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
por: Golden, Thea N., et al.
Publicado: (2022)

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report
por: Park, Chan-Ran, et al.
Publicado: (2023)

Metabolomic Analysis of the Effects of Adipose-Derived Mesenchymal Stem Cell Treatment on Rats With Sepsis-Induced Acute Lung Injury
por: Cui, Yuqing, et al.
Publicado: (2020)

Cryptotanshinone affects HFL-1 cells proliferation by inhibiting cytokines secretion in RAW264.7 cells and ameliorates inflammation and fibrosis in newborn rats with hyperoxia induced lung injury
por: Ma, Mengmeng, et al.
Publicado: (2023)

Alda-1 Attenuates Hyperoxia-Induced Acute Lung Injury in Mice
por: Sidramagowda Patil, Sahebgowda, et al.
Publicado: (2021)

Emodin Ameliorates Acute Pancreatitis-Associated Lung Injury Through Inhibiting the Alveolar Macrophages Pyroptosis
por: Wu, Xiajia, et al.
Publicado: (2022)

Qingfei Litan Decoction Against Acute Lung Injury/Acute Respiratory Distress Syndrome: The Potential Roles of Anti-Inflammatory and Anti-Oxidative Effects
por: Diao, Yirui, et al.
Publicado: (2022)

Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies
por: Gao, Ruo-Lin, et al.
Publicado: (2022)

The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target
por: Wang, Yinghong, et al.
Publicado: (2022)

Plant polysaccharides with anti-lung injury effects as a potential therapeutic strategy for COVID-19
por: Huang, Peng, et al.
Publicado: (2022)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Hordenine Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammation
por: Zhang, Xiyue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2nj49fru0riusc0091c2ikomps